Back العلاج الهرموني للتحول الجنسي Arabic Хормонотерапия при трансполовите хора Bulgarian چارەسەری ھۆرمۆنیی ترانسجێندەر CKB Terapia hormonal transgénero Spanish هورموندرمانی افراد ترنس Persian Transition hormonale French Terapia hormonal para transxénero Galician טיפול הורמונלי להתאמה מגדרית HE Terapi hormon transgender ID 트랜스젠더 호르몬 치료 Korean
| Part of a series on |
| Transgender topics |
|---|
 Category |
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity. This form of hormone therapy is given as one of two types, based on whether the goal of treatment is masculinization or feminization:
- Masculinizing hormone therapy – for transgender men or transmasculine people; consists of androgens and occasionally antiestrogens.
- Feminizing hormone therapy – for transgender women or transfeminine people; consists of estrogens with or without antiandrogens.
Eligibility for GAHT may require an assessment for gender dysphoria or persistent gender incongruence; or many medical institutions now use an informed consent model, which ensures patients are informed of the procedure process, including possible benefits and risks, while removing many of the historical barriers needed to start hormone therapy. Treatment guidelines for therapy have been developed by several medical associations.
Non-binary people may also engage in hormone therapy in order to achieve a desired balance of sex hormones or to help align their bodies with their gender identities.[1] Many transgender people obtain hormone therapy from a licensed health care provider and others obtain and self-administer hormones.
- ^ Ferguson JM (November 30, 2017). "What It Means to Transition When You're Non-Binary". Teen Vogue. Archived from the original on December 13, 2019. Retrieved March 20, 2018.